Cervical cancer rates plummet among states with high HPV vaccination rates
Medical Xpress
February 25, 2026
AI-Generated Deep Dive Summary
Cervical cancer rates have significantly decreased in states where HPV vaccination rates are high, according to a new study. The research, published in the Journal of the National Cancer Institute, reveals that cervical cancers among young women have declined by 27% since the HPV vaccine became available in the United States. This decline underscores the effectiveness of HPV vaccination in preventing cervical cancer and highlights the importance of widespread vaccination.
The HPV virus is a leading cause of cervical cancer, with certain strains responsible for most cases. The HPV vaccine works by targeting these harmful strains, providing protection against infections that can lead to cancer. While the study focuses on young women, it's important to note that HPV can also affect males and contribute to cancers such as throat, anal, and penile cancers. This broader impact emphasizes the value of vaccination for both genders.
States with higher HPV
Verticals
healthmedical
Originally published on Medical Xpress on 2/25/2026